2SEVENTY BIO INC (TSVT) Stock Income Statement
NASDAQ:TSVT - Nasdaq - US9013841070 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 37.86M | 100.39M | 91.50M | 54.50M | 248.10M | |||
| Cost Of Goods | 18.01M | 16.92M | 16.60M | 2.50M | 5.40M | |||
| Gross Profit | 19.85M | 83.47M | 74.90M | 52.00M | 242.70M | |||
| Operating Expenses | 118.43M | 300.41M | 328.40M | 355.90M | 380.90M | |||
| Research and Development | 76.92M | 230.76M | 248.70M | 261.90M | 296.50M | |||
| Selling, General, and Administrative Expenses | 43.92M | 69.41M | 79.50M | 93.50M | 90.90M | |||
| Operating Income | -98.57M | -216.94M | -253.50M | -303.80M | -138.20M | |||
| Interest Income/Expense | 10.88M | 12.41M | 2.90M | 100.00K | 0.00 | |||
| Other Income/Expense | 4.35M | 7.63M | 6.10M | 21.60M | 18.10M | |||
| Non Recurring Items | -16.86M | -20.67M | -9.60M | -10.10M | N/A | |||
| Income Before Taxes | -57.25M | -217.57M | -254.20M | -292.20M | -120.10M | |||
| Income Tax | 0.00 | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -57.25M | -217.57M | -254.20M | -292.20M | -120.10M | |||
| EBITDA | -91.48M | -206.65M | -241.97M | -287.45M | -125.01M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.10 | -4.42 | -7.13 | -12.44 | -5.14 | |||
| Non GAAP EPS | -1.12 | -4.02 | -7.58 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 52.43% | 83.15% | 81.86% | 95.41% | 97.82% | |||
| Profit Margin | -151.20% | -216.73% | -277.81% | -536.15% | -48.41% | |||
| Operating Profit Margin | -260.35% | -216.10% | -277.05% | -557.43% | -55.70% | |||
All data in USD